Vanguard Capital Management’s Indaptus Therapeutics INDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$313K Buy
135,978
+102,326
+304% +$218K ﹤0.01% 3744
2026
Q2
$101K Buy
+33,652
New +$84.7K ﹤0.01% 3879

Other funds holding INDP

Vanguard Capital Management's INDP Position: Q3 2026 in Review

Vanguard Capital Management increased its Indaptus Therapeutics (INDP) stake by 304% in Q3 2026, buying an estimated $218K and bringing the position to 135,978 shares worth $313K. The position accounts for ﹤0.01% of the portfolio, ranked #3744.

Vanguard Capital Management first reported a position in INDP in Q2 2026 and has held it in 2 quarters since. 20 funds tracked by Wall St. Rank hold INDP as of Q3 2026.

  • Vanguard Capital Management held 135,978 shares of Indaptus Therapeutics worth $313K as of Q3 2026.
  • Vanguard Capital Management bought 102,326 Indaptus Therapeutics shares in Q3 2026, an estimated $218K.
  • Indaptus Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3744 holding.
  • Vanguard Capital Management first reported a position in Indaptus Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 20 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.